Kazia Therapeutics Limited (KZIA)
US Market

Kazia Therapeutics Financial Statements

Kazia Therapeutics Financial Overview

Kazia Therapeutics's market cap is currently ―. The company's EPS TTM is A$-0.841; its P/E ratio is -2.03; Kazia Therapeutics is scheduled to report earnings on September 1, 2022, and the estimated EPS forecast is A$-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Jun 20
Income Statement
Total RevenueA$ ―A$ ―A$ ―
Gross ProfitA$ ―A$ ―A$ ―
EBITA$ ―A$ ―A$ ―
EBITDAA$ ―A$ ―A$ ―
Net Income Common StockholdersA$ ―A$ ―A$ ―
Balance Sheet
Cash, Cash Equivalents and Short-Term InvestmentsA$ 8.76MA$ 15.19MA$ 19.37M
Total AssetsA$ 44.67MA$ 39.61MA$ 23.06M
Total DebtA$ 0.00A$ 0.00A$ 0.00
Net DebtA$ -8.76MA$ -15.19MA$ -19.37M
Total LiabilitiesA$ 19.18MA$ 7.94MA$ 8.94M
Stockholders EquityA$ 14.13MA$ 25.49MA$ 31.68M
Cash Flow
Free Cash FlowA$ -2.69MA$ -10.04MA$ -2.75M
Operating Cash FlowA$ ―A$ ―A$ ―
Investing Cash FlowA$ -278.00A$ ―A$ ―
Financing Cash FlowA$ 16.70KA$ 23.60MA$ 8.40M
Currency in AUD

Kazia Therapeutics Earnings and Revenue History

Kazia Therapeutics Debt to Assets

Kazia Therapeutics Cash Flow

Kazia Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis